Diagnostic Biomarkers in Metabolomics

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker reveals further information to presently existing clinical and pathological analysis. It facilitates screening and detecting the disease, monitoring the progression of the disease, and predicting the diagnosis and survival after clinical intervention. A biomarker can also be used to evaluate the process of drug development and optimally to improve the efficacy and safety of disease treatment by enabling physicians to tailor treatment for individual patients. These emerging biomarkers will be beneficial and critical in developing new and clinically reliable indicators that will have a high specificity for the diagnosis.

  • Metabolite platform for validation of biomarkers
  • Biomarkers in drug development
  • Disease related biomarkers
  • Imaging biomarkers
  • Metabolomics in biomarker discovery

Related Conference of Diagnostic Biomarkers in Metabolomics

June 12-13, 2025

6th International Conference on Drug Chemistry

London, UK
July 14-15, 2025

15th World Glycobiology Congress

Berlin, Germany
July 17-18, 2025

16th International Conference on Biofuels and Bioenergy

Amsterdam, Netherlands
September 08-09, 2025

23rd International Conference on Structural Biology

Frankfurt, Germany

Diagnostic Biomarkers in Metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in